Despite not being officially recalled, Zantac is being withdrawn from the shelves of several pharmacies amid concerns over potential cancer risks.
The well-known heartburn medication Zantac is facing scrutiny after recent studies indicated the presence of a carcinogenic substance. In September, the FDA alerted consumers about the detection of NDMA, a chemical classified as a “probable carcinogen,” in ranitidine-based products, including Zantac and its generics. This chemical has previously led to recalls of certain blood pressure medications.
Currently, the FDA is conducting an investigation and has requested that manufacturers of Zantac and its equivalents test their products for NDMA and report their findings. At this stage, the agency has not advised patients to discontinue use of the medication and is awaiting further information on the concentration of NDMA present in these products.
“The FDA is collaborating with global regulators and industry stakeholders to identify the source of this impurity in ranitidine. We are examining the levels of NDMA in ranitidine and assessing any potential risks to patients. Appropriate actions will be determined based on the results of our ongoing investigation,” the FDA stated.
In a proactive measure, however, major pharmacy chains like Rite-Aid, Walgreens, and CVS have chosen to halt the sales of Zantac and its generics, citing an abundance of caution. CVS has also stated that customers who purchased Zantac or its generic forms can return the product for a refund.
While there has not been a formal recall, two manufacturers of generic ranitidine, Apotex and Sandoz, have voluntarily recalled their products. Zantac is frequently used by individuals, including pregnant women, who seek relief from heartburn, raising concerns about the implications of this situation.
For now, there’s no need for alarm, as the FDA continues its investigation. If you have concerns about your use of Zantac, consider discussing alternative heartburn medications with your healthcare provider. There are numerous safe and effective options available. For more information, you can read our other blog posts on related topics here.
Additionally, for those exploring the journey of pregnancy and home insemination, Make a Mom offers valuable resources. The CDC also provides an excellent guide on reproductive health and infertility that can be found here.
In summary, while Zantac remains on the market, its availability is being strained by safety concerns regarding NDMA. Major pharmacies are taking precautions while the FDA continues to investigate.